Drug Profile
PF 4480682
Alternative Names: PF-4480682Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 31 Mar 2009 Discontinued - Phase-II for Neuropathic pain in USA (unspecified route)
- 30 Sep 2008 Phase-II clinical trials in Neuropathic pain in USA (unspecified route)